Source link : https://newshealth.biz/health-news/ai-pathology-shows-efruxifermin-benefits-in-mash-cirrhosis/

AI-based digital pathology revealed that efruxifermin had an additional impact on septa area as well as fibrosis in a post hoc analysis of the SYMMETRY study. Medscape Medical News Source link : https://www.medscape.com/viewarticle/ai-pathology-shows-efruxifermin-benefits-mash-cirrhosis-2025a1000viw?src=rss Author : Publish date : 2025-11-13 11:27:00 Copyright for syndicated content belongs to the linked Source.

The post AI Pathology Shows Efruxifermin Benefits in MASH, Cirrhosis first appeared on News Health.

—-

Author : News Health

Publish date : 2025-11-13 11:27:00

Copyright for syndicated content belongs to the linked Source.

—-

12345678